Director, Global Access Strategy & Pricing COVID-19 treatments (Secondment 6 - 7 months)

ROLE SUMMARY

The Director, Global Access Strategy & Pricing, COVID-19 treatment role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance on access, pricing, optimal reimbursement, launch sequencing, patient value, and Access evidence requirements for COVID-19 treatments, with a near-term focus on Paxlovid.

This colleague will support the Access Strategy & Pricing Team Lead and be a core member of the matrix Access & Value Team to develop, refine, and operationalize the Integrated Value & Access Strategy for Paxlovid and other Pfizer COVID-19 treatments. They will be responsible for overseeing and supporting markets as they transition Paxlovid from advance purchase agreement to commercialization and reimbursement, or as they renegotiate current access and lifecycle events. This will include development and maintenance of resources critical to country launch readiness, such as value proposition, negotiation trainings, pricing guidance and launch timing, and review and approval of pricing business cases. They will also lead Global, Regional and Local partnerships and generate payer & market insights to ensure robust evidence generation to support pricing & market access recommendations.

ROLE RESPONSIBILITIES

• In collaboration with the Access & Value matrix team, orchestrate and evolve the Integrated Value & Access Strategy (IVAS) for Paxlovid in response to competition, environmental changes & lifecycle management:

  • Deliver recommendations relating to Pricing and Access Strategy, Access evidence needs and value proposition, taking into consideration market archetype and lifecycle considerations. 

  • Lead/support the updates of launch deliverables including the brand/s: Payer Value Proposition (PVP), Pricing and Access strategy and related payer research
     

• Support EM Country Access and Value (CAV) colleagues as they engage local stakeholders on access and pricing, by providing training, negotiation tools, advice and connections with experts as appropriate.

• Identify and execute opportunities to expand INTL Access for COVID-19 treatments

• Support Next Gen Early Engagement work with prioritized Access & Value stakeholders across EM

• Ensure tailer made Access support for EM, so specific access needs are addressed in Global RWE strategy & economic model adaptions

• Develop innovative or original ideas, lead division projects and develop plans that achieve meaningful outcomes and business impact

• Identify innovative Access & Value solutions to overcome current/future obstacles to COVID treatment funding & uptake

• Lead GAV CAV community engagement initiatives, and updates.

• Champion the Payer and Value perspective internally and improve understanding of payer needs

• Remain fully compliant to all Pfizer SOPs (Standard Operating Procedures).

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• Bachelor’s Degree minimum required, master’s degree in a healthcare, business or economic field preferred.

• Knowledge and experience of drug development processes, and technical knowledge of health economics and pricing/access required

• Minimum of 8 years’ experience in healthcare environment, preferably pharmaceutical industry or related consulting services, sufficient to have developed a deep understanding of the global payer and Value & Access environment

• Expert understanding of fundamental Access & Value methods & tools for international markets including, but not limited to:

  • Basic understanding of epidemiology, health economics and outcomes research and real-world evidence frameworks/tools

  • Experience with health technology assessments (such as NICE, SMC, PBAC) is desirable.

  • Development & maintenance of payer value propositions & global value dossiers

  • Development of value-based pricing strategies

  • Familiarity with strategic and operating planning processes

  • Experience in functioning within matrix organizations where managing through influence is required

  • Pharmaceutical business leadership, including experience in strategy development and interaction with customers

• An “execution mindset” focused on getting things done quickly and simply

  • Ability to work under pressure, to take accountability for business challenges, think strategically and tackle complex problems

  • Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities in a compliant manner

  • Strong project management abilities (contracting, budgeting, vendor management) essential.

• Strong interpersonal skills and evidence of teamwork in a matrix environment

  • Proven ability to build coalitions and develop strong partnerships across functions

  • Strong customer-orientation; an ability to see issues from the point of view of others

  • Ability to work successfully and cooperatively with colleagues across multiple cultures and time-zones

• Intellectual curiosity and ability to spot trends/patterns

• Outstanding writing and presentation skills

• Excellent oral and written English communication skills

Other Job Details:

• Last Date to Apply for Job: June 13, 2025

• Additional Location Information: North America - Remote, Europe - Remote, Global - Remote

• Eligible for Relocation Package – NO

• Secondment 6-7 months

• If you are currently in a driving position with a fleet vehicle and this secondment does not require driving as an essential function of the position for 12 months or longer, you will be required to turn in your fleet vehicle for the duration of the non-driving secondment.  Please refer to the Fleet Policy and Procedures document for more information.

• Note: This secondment offers a valuable opportunity for professional growth. It will need to be funded by the secondee’s home market.

Relocation assistance may be available based on business needs and/or eligibility.